Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice. / Pinto, Fernanda E.; Olsen, Peter; Glud, Martin; Wulf, Hans Christian; Lerche, Catharina M.

In: Photochemistry and Photobiology, Vol. 98, No. 6, 2022, p. 1390-1394.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pinto, FE, Olsen, P, Glud, M, Wulf, HC & Lerche, CM 2022, 'Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice', Photochemistry and Photobiology, vol. 98, no. 6, pp. 1390-1394. https://doi.org/10.1111/php.13622

APA

Pinto, F. E., Olsen, P., Glud, M., Wulf, H. C., & Lerche, C. M. (2022). Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice. Photochemistry and Photobiology, 98(6), 1390-1394. https://doi.org/10.1111/php.13622

Vancouver

Pinto FE, Olsen P, Glud M, Wulf HC, Lerche CM. Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice. Photochemistry and Photobiology. 2022;98(6):1390-1394. https://doi.org/10.1111/php.13622

Author

Pinto, Fernanda E. ; Olsen, Peter ; Glud, Martin ; Wulf, Hans Christian ; Lerche, Catharina M. / Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice. In: Photochemistry and Photobiology. 2022 ; Vol. 98, No. 6. pp. 1390-1394.

Bibtex

@article{0882d08408b14fa594e4b05b1ba28dbc,
title = "Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice",
abstract = "We investigated whether topical brimonidine delayed or enhanced the development of squamous cell carcinoma (SCC) when ultraviolet radiation (UVR) was applied to a well-established murine model. Hairless female mice (n = 125) were randomized into five groups and treated as follows: 1% brimonidine cream before UVR (Group 1), 0.33% brimonidine gel before UVR (Group 2), 1% brimonidine cream after UVR (Group 3), UVR only (control; Group 4) and 1% brimonidine cream only (control; Group 5). For each animal, the first four tumors were recorded and followed until three tumors reached 4 mm or one tumor reached 12 mm in diameter. All animal experiments continued for up to 365 days or until death. Application of 1% brimonidine cream before UVR delayed tumor development relative to control mice treated with UVR alone (P = 0.000006). However, when 0.33% brimonidine gel was applied before UVR (P = 0.313) or 1% brimonidine cream was applied after UVR (P = 0.252), there was no significant delay in tumor development relative to control mice treated with UVR alone. The development of the second and third tumors followed a similar pattern. Topical 1% brimonidine cream applied before UVR exposure delayed SCC development in hairless mice. In contrast, when brimonidine was applied after UVR there was no significant delay in tumor development. These results suggest that the 1% brimonidine cream probably absorbed the UVR, and therefore, a delay in tumor formation was only seen when brimonidine was applied before irradiation. However, there can be multiple reasons for this delay in photocarcinogenesis.",
author = "Pinto, {Fernanda E.} and Peter Olsen and Martin Glud and Wulf, {Hans Christian} and Lerche, {Catharina M.}",
note = "Funding Information: This work was executed as part of the Skin Cancer Innovation Clinical Academic Group (SCIN CAG), Greater Copenhagen Health Science Partners (GCHSP) and Danish Research Center for Skin Cancer. The research was supported by Copenhagen University Hospital, Bispebjerg and Kgl. Hofbundtmager Aage Bangs Foundation. C.M.L is supported by an unrestricted grant from the Lundbeck Foundation (R307‐2018‐3318). ",
year = "2022",
doi = "10.1111/php.13622",
language = "English",
volume = "98",
pages = "1390--1394",
journal = "Photochemistry and Photobiology",
issn = "0031-8655",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice

AU - Pinto, Fernanda E.

AU - Olsen, Peter

AU - Glud, Martin

AU - Wulf, Hans Christian

AU - Lerche, Catharina M.

N1 - Funding Information: This work was executed as part of the Skin Cancer Innovation Clinical Academic Group (SCIN CAG), Greater Copenhagen Health Science Partners (GCHSP) and Danish Research Center for Skin Cancer. The research was supported by Copenhagen University Hospital, Bispebjerg and Kgl. Hofbundtmager Aage Bangs Foundation. C.M.L is supported by an unrestricted grant from the Lundbeck Foundation (R307‐2018‐3318).

PY - 2022

Y1 - 2022

N2 - We investigated whether topical brimonidine delayed or enhanced the development of squamous cell carcinoma (SCC) when ultraviolet radiation (UVR) was applied to a well-established murine model. Hairless female mice (n = 125) were randomized into five groups and treated as follows: 1% brimonidine cream before UVR (Group 1), 0.33% brimonidine gel before UVR (Group 2), 1% brimonidine cream after UVR (Group 3), UVR only (control; Group 4) and 1% brimonidine cream only (control; Group 5). For each animal, the first four tumors were recorded and followed until three tumors reached 4 mm or one tumor reached 12 mm in diameter. All animal experiments continued for up to 365 days or until death. Application of 1% brimonidine cream before UVR delayed tumor development relative to control mice treated with UVR alone (P = 0.000006). However, when 0.33% brimonidine gel was applied before UVR (P = 0.313) or 1% brimonidine cream was applied after UVR (P = 0.252), there was no significant delay in tumor development relative to control mice treated with UVR alone. The development of the second and third tumors followed a similar pattern. Topical 1% brimonidine cream applied before UVR exposure delayed SCC development in hairless mice. In contrast, when brimonidine was applied after UVR there was no significant delay in tumor development. These results suggest that the 1% brimonidine cream probably absorbed the UVR, and therefore, a delay in tumor formation was only seen when brimonidine was applied before irradiation. However, there can be multiple reasons for this delay in photocarcinogenesis.

AB - We investigated whether topical brimonidine delayed or enhanced the development of squamous cell carcinoma (SCC) when ultraviolet radiation (UVR) was applied to a well-established murine model. Hairless female mice (n = 125) were randomized into five groups and treated as follows: 1% brimonidine cream before UVR (Group 1), 0.33% brimonidine gel before UVR (Group 2), 1% brimonidine cream after UVR (Group 3), UVR only (control; Group 4) and 1% brimonidine cream only (control; Group 5). For each animal, the first four tumors were recorded and followed until three tumors reached 4 mm or one tumor reached 12 mm in diameter. All animal experiments continued for up to 365 days or until death. Application of 1% brimonidine cream before UVR delayed tumor development relative to control mice treated with UVR alone (P = 0.000006). However, when 0.33% brimonidine gel was applied before UVR (P = 0.313) or 1% brimonidine cream was applied after UVR (P = 0.252), there was no significant delay in tumor development relative to control mice treated with UVR alone. The development of the second and third tumors followed a similar pattern. Topical 1% brimonidine cream applied before UVR exposure delayed SCC development in hairless mice. In contrast, when brimonidine was applied after UVR there was no significant delay in tumor development. These results suggest that the 1% brimonidine cream probably absorbed the UVR, and therefore, a delay in tumor formation was only seen when brimonidine was applied before irradiation. However, there can be multiple reasons for this delay in photocarcinogenesis.

U2 - 10.1111/php.13622

DO - 10.1111/php.13622

M3 - Journal article

C2 - 35338500

AN - SCOPUS:85128112559

VL - 98

SP - 1390

EP - 1394

JO - Photochemistry and Photobiology

JF - Photochemistry and Photobiology

SN - 0031-8655

IS - 6

ER -

ID: 308042341